1- Mendes FB, Hissa-Elian A, Abreu MA, Gonçalves VS. Review: dermatitis herpetiformis. An Bras Dermatol. 2013 Jul-Aug;88(4):594-9.
2. Michaëlsson G, Gerdén B, Ottosson M, et al. Patients with psoriasis often have increased serum levels of IgA antibodies to gliadin. Br J Dermatol. 1993;129:667-73.
3. Sultan SJ, Ahmad QM, Sultan ST. Antigliadin antibodies in psoriasis. Australas J Dermatol. 2010;51:238-42.
4. Nagui N, El Nabarawy E, Mahgoub D,et al. Estimation of (IgA) anti-gliadin, anti-endomysium and tissue transglutaminase in the serum of patients with psoriasis. Clin Exp Dermatol. 2011;6:302-4.
5. Akbulut S, Gür G, Topal F, et al. Coeliac disease-associated antibodies in psoriasis. Ann Dermatol. 2013;25:298-303.
6. Rudsander Lindqvist U,A, Boström A, Nilsson B, Michaëlsson G. IgA antibodies to gliadin and coeliac disease in psoriatic arthritis. Rheumatology (Oxford). 2002 ;41:31-7.
7. Lundin A, Fredens K, Michaëlsson G, Venge P. The eosinophil granulocyte in psoriasis. Br J Dermatol. 1990;122:181-93.
8. Mansur AT, Göktay F, Yaşar SP. Peripheral blood eosinophilia in association with generalized pustular and erythrodermicpsoriasis. J Eur Acad Dermatol Venereol. 2008;22:451-5.
9. Kim TY, Park HJ, Kim CW. Eosinophil cationic protein (ECP) level and its correlation with eosinophil number or IgE level of peripheral blood in patients with various skin diseases. J Dermatol Sci. 1997;15:89-94.
10. Michaëlsson G, Kraaz W, Gerdén B, et al. Patients with psoriasis have elevated levels of serum eosinophil cationic protein and increased numbers of EG2 positive eosinophils in the duodenal stroma. Br J Dermatol. 1996;135:371-8.
11. Michaëlsson G, Kraaz W, Hagforsen E, et al. Psoriasis patients have highly increased numbers of tryptase-positive mast cells in the duodenal stroma. Br J Dermatol. 1997;136:866-70.
12. Silverberg NB. Pediatric vitiligo. Pediatr Clin North Am. 2014 ;61:347-66.
13. Reunala T, Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol. 1997;136:315-8.
14. Shahmoradi Z, Najafian J, Naeini FF, Fahimipour F. Vitiligo and autoantibodies of celiac disease. Int J Prev Med. 2013;4:200-3.
15. Rodríguez-García C, González-Hernández S, Pérez-Robayna N,et al. Repigmentation of vitiligo lesions in a child with celiac disease after a gluten-free diet. Pediatr Dermatol. 2011;28:209-10. 16. Khandalavala BN, Nirmalraj MC. Rapid partial repigmentation of vitiligo in a young female adult with a gluten-free diet. Case Rep Dermatol. 2014;6(3):283-7.
17. Aroni K, Voudouris S, Ioannidis E, et al. Increased angiogenesis and mast cells in the centre compared to the periphery of vitiligo lesions. Arch Dermatol Res. 2010;302:601-7.
18. Panja SK, Bhattacharya B, Lahiri SC.Role of histamine as a toxic mediator in the pathogenesis of vitiligo. 2013 Nov;58(6):421-8.
19. Mohan GC, Silverberg JI.Association of Vitiligo and Alopecia Areata With Atopic Dermatitis: A Systematic Review and Meta-analysis. JAMA Dermatol. 2015;151:522-8.
20. Huang KP, Mullangi S, Guo Y, Qureshi AA.Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol. 2013;149:789-94.
21. Corazza GR, Andreani ML, Venturo N, et al. Celiac disease and alopecia areata: report of a new association. Gastroenterology. 1995;109:1333-7.
22. Bardella MT, Marino R, Barbareschi M,et al. Alopecia areata and coeliac disease: no effect of a gluten-free diet on hair growth. Dermatology. 2000;200:108-10.
23. Fessatou S, Kostaki M, Karpathios T. Coeliac disease and alopecia areata in childhood. J Paediatr Child Health. 2003;39:152-4.
24. Viola F, Barbato M, Formisano M, et al. Reappearance of alopecia areata in a coeliac patient during an unintentional challenge with gluten. Minerva Gastroenterol Dietol. 1999;45:283-5.
